Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

ADAP Adaptimmune Therapeutics PLC

0,66

0,0234 (3,68%)

23 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Adaptimmune Therapeutics (NASDAQ:ADAP)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Adaptimmune Therapeutics Charts.

Adaptimmune Therapeutics (NASDAQ:ADAP)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Adaptimmune Therapeutics Charts.

News Adaptimmune Therapeutics PLC

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 13 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 13 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 13 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 1 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 23 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 12 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 12 August 2024 (3 Monate vor) • Edgar (US Regulatory)

U.S. Futures Steady as Markets Await Key Inflation Data, Oil Prices Climb
Montag 12 August 2024 (3 Monate vor) • IH Market News

Form 8-K - Current report
Freitag 2 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Adaptimmune Receives U.S. FDA Accelerated Approval of TECELRA® (afamitresgene autoleucel), the First Approved Engineered Cell Therapy for a Solid Tumor
Freitag 2 August 2024 (4 Monate vor) • Business Wire

Form 8-K - Current report
Dienstag 16 Juli 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 18 Juni 2024 (5 Monate vor) • Edgar (US Regulatory)

Weitere Adaptimmune Therapeutics PLC News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen